Evidence map›Paper›PMID 38117827›Full record

ArticlePloS one2023

The relationship between sleep, gut microbiota, and metabolome in patients with depression and anxiety: A secondary analysis of the observational study.

Arisa Tanaka, Kenji Sanada, Katsuma Miyaho, Tomoyuki Tachibana, Shunya Kurokawa, Chiharu Ishii, Yoshihiro Noda, Shinichiro Nakajima, Shinji Fukuda, Masaru Mimura and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Pharmaceutical biology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Increased relative abundance ofFrontiers in sleep · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Arisa TanakaDepartment of Psychiatry, Showa University Karasuyama Hospital, Tokyo, Japan.
Kenji SanadaDepartment of Psychiatry, Showa University Karasuyama Hospital, Tokyo, Japan.ORCID 0000-0002-3125-7453
Katsuma MiyahoDepartment of Psychiatry, Showa University Karasuyama Hospital, Tokyo, Japan.
Tomoyuki TachibanaDepartment of Psychiatry, Showa University Karasuyama Hospital, Tokyo, Japan.
Shunya KurokawaDepartment of Neuropsychiatry, Keio University Hospital, Tokyo, Japan.
Chiharu IshiiInstitute for Advanced Biosciences, Keio University, Yamagata, Japan.
Yoshihiro NodaDepartment of Neuropsychiatry, Keio University Hospital, Tokyo, Japan.ORCID 0000-0002-2155-0357
Shinichiro NakajimaDepartment of Neuropsychiatry, Keio University Hospital, Tokyo, Japan.
Shinji FukudaInstitute for Advanced Biosciences, Keio University, Yamagata, Japan.
Masaru MimuraDepartment of Neuropsychiatry, Keio University Hospital, Tokyo, Japan.
Taishiro KishimotoDepartment of Neuropsychiatry, Keio University Hospital, Tokyo, Japan.
Akira IwanamiDepartment of Psychiatry, Showa University Karasuyama Hospital, Tokyo, Japan.
Keio University Hospital · JPShowa University · JPKeio University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGrowing attention is paid to the association between alterations in the gut microbiota and their metabolites in patients with psychiatric disorders. Our study aimed to determine how gut microbiota and metabolomes are related to the sleep quality among patients with depression and anxiety disorders by analyzing the datasets of our previous study.

methodsSamples were collected from 40 patients (depression: 32 patients [80.0%]); anxiety disorders: 8 patients [20.0%]) in this study. Gut microbiomes were analyzed using 16S rRNA gene sequencing and gut metabolomes were analyzed by a mass spectrometry approach. Based on the Pittsburgh Sleep Quality Index (PSQI), patients were categorized into two groups: the insomnia group (PSQI score ≥ 9, n = 20) and the non-insomnia group (PSQI score < 9, n = 20).

resultsThe insomnia group showed a lower alpha diversity in the Chao1 and Shannon indices than the non-insomnia group after the false discovery rate (FDR) correction. The relative abundance of genus Bacteroides showed a positive correlation with PSQI scores in the non-insomnia group. The concentrations of glucosamine and N-methylglutamate were significantly higher in the insomnia group than in the non-insomnia group.

conclusionsOur findings suggest that specific taxa could affect the sleep quality among patients with depression and anxiety disorders. Further studies are needed to elucidate the impact of sleep on specific gut microbiota and metabolomes in depression and anxiety disorders.

Indexed as

Gastrointestinal MicrobiomeSleep Initiation and Maintenance DisordersAnxietyAnxiety DisordersDepressionHumansMetabolomeObservational Studies as TopicRNA, Ribosomal, 16SSleepRNA, Ribosomal, 16S

Identifiers

PMID38117827
PMCPMC10732403
OpenAlexW4390037728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.